Sandrine Pereira
Overview
Explore the profile of Sandrine Pereira including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
33
Citations
791
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Popotte C, Berthel E, Letellier R, Rancati T, Orlandi E, Munier M, et al.
Cancer Radiother
. 2024 Sep;
28(5):449-452.
PMID: 39294024
Purpose: In head and neck squamous cell carcinoma (HNSCC), early complications of the radiotherapy (RT) are observed from the beginning of the treatment to a few months after its end....
2.
Berthel E, Pujo-Menjouet L, Le Reun E, Sonzogni L, Al-Choboq J, Chekroun A, et al.
Cells
. 2023 Jul;
12(13).
PMID: 37443782
Alzheimer's disease (AD) is the most common neurodegenerative dementia, for which the molecular origins, genetic predisposition and therapeutic approach are still debated. In the 1980s, cells from AD patients were...
3.
Pereira S, Orlandi E, Deneuve S, Barcellini A, Chalaszczyk A, Behm-Ansmant I, et al.
Cancers (Basel)
. 2022 Dec;
14(24).
PMID: 36551737
(1) Background: radiotherapy is a cornerstone of cancer treatment. When delivering a tumoricidal dose, the risk of severe late toxicities is usually kept below 5% using dose-volume constraints. However, individual...
4.
Deneuve S, Bastogne T, Duclos M, Mirjolet C, Bois P, Bachmann P, et al.
Tumori
. 2022 May;
109(2):173-185.
PMID: 35578746
Objective: Radiotherapy (RT) against head and neck squamous cell carcinomas (HNSCC) may lead to severe toxicity in 30-40% of patients. The normal tissue complication probability (NTCP) models, based on dosimetric...
5.
Viau M, Sonzogni L, Ferlazzo M, Berthel E, Pereira S, Bodgi L, et al.
Biomolecules
. 2021 Oct;
11(10).
PMID: 34680095
Despite a considerable amount of data, the molecular and cellular bases of the toxicity due to metal exposure remain unknown. Recent mechanistic models from radiobiology have emerged, pointing out that...
6.
Deneuve S, Mirjolet C, Bastogne T, Duclos M, Retif P, Zrounba P, et al.
Cancers (Basel)
. 2021 Jun;
13(10).
PMID: 34069662
Radiation therapy (RT), either alone or in combination with surgery and/or chemotherapy is a keystone of cancers treatment. Early toxicity is common, sometimes leading to discontinuation of treatment. Recent studies...
7.
Ferlazzo M, Berthel E, Granzotto A, Devic C, Sonzogni L, Bachelet J, et al.
Int J Radiat Biol
. 2019 Nov;
96(3):394-410.
PMID: 31738647
Xeroderma Pigmentosum (XP) is a rare, recessive genetic disease associated with photosensitivity, skin cancer proneness, neurological abnormalities and impaired nucleotide excision repair of the UV-induced DNA damage. Less frequently, XP...
8.
Vogin G, Bastogne T, Bodgi L, Gillet-Daubin J, Canet A, Pereira S, et al.
Int J Radiat Oncol Biol Phys
. 2018 Jun;
101(3):690-693.
PMID: 29893278
Purpose: The ability to identify, before treatment, those patients who will overreact to radiation therapy would have sound positive clinical implications. By focusing on DNA double-strand breaks recognition and repair...
9.
Pereira S, Bodgi L, Duclos M, Canet A, Ferlazzo M, Devic C, et al.
Int J Radiat Oncol Biol Phys
. 2018 May;
101(2):491-492.
PMID: 29726366
No abstract available.
10.
Pereira S, Bodgi L, Duclos M, Canet A, Ferlazzo M, Devic C, et al.
Int J Radiat Oncol Biol Phys
. 2018 Jan;
100(2):353-360.
PMID: 29353653
Purpose: To examine the possibility of predicting clinical radiosensitivity by quantifying the nuclear forms of autophosphorylated ATM protein (pATM) via a specific enzyme-linked immunosorbent assay (ELISA). Methods And Materials: This...